A phase I/II study of high dose allogeneic GM-CSF gene-transduced prostate cancer cell line vaccine in patients with metastatic hormone-refractory prostate cancer. - Simons,J.; Higano,C.; Corman,J.; Hudes,G.; Centeno,A.; Dula,E.; Smith,D.; Steidle,C.; Sacks,N.; Small,E. (Proc Am Soc Clin Oncol, 2003)